Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials

Overview of attention for article published in European Heart Journal, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (74th percentile)

So far, Altmetric has seen 1 public wall post.

AbstractAims. It is unknown whether cardioversion of atrial fibrillation causes thromboembolic events or is a risk marker. To…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.